Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study

Physical exercise has demonstrated benefits for managing nonalcoholic fatty liver disease (NAFLD). However, in daily life maintaining exercise without help may be difficult. A whole‐body vibration device (WBV) has been recently introduced as an exercise modality that may be suitable for patients who have difficulty engaging in exercise. We tested WBV in patients with NAFLD and estimated its effectiveness. We studied the effects of a 6‐month WBV program on hepatic steatosis and its underlying pathophysiology in 25 patients with NAFLD. Seventeen patients with NAFLD were designated as a control group. After WBV exercise, body weight in the study group decreased by only 2.5% compared with the control group. However, we found significant increases in muscle area (+2.6%) and strength (+20.5%) and decreases in fat mass (−6.8%). The hepatic (−9.9%) and visceral (−6.2%) fat content also significantly decreased (P < 0.05). There was substantial lowering of hepatic stiffness (−15.7%), along with improvements in the levels of inflammatory markers; tumor necrosis factor alpha (−50.9%), adiponectin (+12.0%), ferritin (−33.2%), and high‐sensitivity C‐reactive protein (−43.0%) (P < 0.05). These results suggest that WBV is an exercise option for patients with NAFLD that is effective, efficient, and convenient.